Efficacy and safety of tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps overall and in patients with and without co-morbid asthma: Results from the phase 3 WAYPOINT study Meeting Abstract

publication date

  • December 1, 2025

webpage

published in

volume

  • 80